To determine whether genetically determined immune response factors co
uld be involved in the pathogenesis of hepatocellular carcinoma, we pe
rformed HLA-A and HLA-B typing in 55 black patients with histologicall
y-proven hepatocellular carcinoma, and HLA-DR and HLA-DQ typing in 47
of these patients. The HLA typing was also carried out in a control gr
oup of normal black patients. The HLA typing was done by a standard mi
crolymphocytotoxicity method. No difference in HLA-A, HLA-DR and HLA-D
Q frequencies between patients and controls were noted. HLA-B21 was pr
esent in 10.9% of patients compared to 1.8% of control subjects (corre
cted p<0.005; relative risk = 6.6) and HLA-B49 was present in 7.3% of
patients compared with 1.1% of normal control subjects (corrected p<0.
007; relative risk = 7.1), These findings suggest that genetic factors
may play a role in the pathogenesis of hepatocellular carcinoma.